Literature DB >> 18056034

Perspective on the osteoclast: an angiogenic cell?

Frank C Cackowski1, G David Roodman.   

Abstract

There have been reports recently that the osteoclast stimulates angiogenesis in vitro. We review the evidence suggesting that the osteoclast directly stimulates angiogenesis, and discuss the feasibility of the hypothesis that the osteoclast can be a proangiogenic cell. Reasons supporting the feasibility of this hypothesis include proangiogenic factors produced by osteoclasts, the angiogenic effects of macrophages, the antiangiogenic effects of nitrogen containing bisphosphonates, and the physical proximity of osteoclasts to endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056034     DOI: 10.1196/annals.1402.073

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.

Authors:  Alexandre Bruni-Cardoso; Lindsay C Johnson; Robert L Vessella; Todd E Peterson; Conor C Lynch
Journal:  Mol Cancer Res       Date:  2010-03-23       Impact factor: 5.852

2.  Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.

Authors:  Yongfen Min; Xiubao Ren; David B Vaught; Jin Chen; Edwin Donnelly; Conor C Lynch; P Charles Lin
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

Review 3.  Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

Authors:  Jian Zhang; Yi Lu; Kenneth J Pienta
Journal:  J Natl Cancer Inst       Date:  2010-03-16       Impact factor: 13.506

Review 4.  The endothelium-bone axis in development, homeostasis and bone and joint disease.

Authors:  Jan Tuckermann; Ralf H Adams
Journal:  Nat Rev Rheumatol       Date:  2021-09-03       Impact factor: 20.543

5.  A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

Authors:  Xin Li; Robert Loberg; Jinhui Liao; Chi Ying; Linda A Snyder; Kenneth J Pienta; Laurie K McCauley
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

6.  Hemangioma of the mandible: case report with special emphasis on bone degradation.

Authors:  Torsten Hansen; Martin Kunkel; Detlef Katenkamp; Sami Eletr; Wilfried Wagner
Journal:  Oral Maxillofac Surg       Date:  2009-12

Review 7.  The cast of clasts: catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts.

Authors:  Paul R Odgren; Hanna Witwicka; Pablo Reyes-Gutierrez
Journal:  Connect Tissue Res       Date:  2016-01-28       Impact factor: 3.417

Review 8.  CCL2/CCR2 signaling in cancer pathogenesis.

Authors:  Qiongyu Hao; Jaydutt V Vadgama; Piwen Wang
Journal:  Cell Commun Signal       Date:  2020-05-29       Impact factor: 5.712

9.  Engineered osteoclasts as living treatment materials for heterotopic ossification therapy.

Authors:  Wenjing Jin; Xianfeng Lin; Haihua Pan; Chenchen Zhao; Pengcheng Qiu; Ruibo Zhao; Zihe Hu; Yanyan Zhou; Haiyan Wu; Xiao Chen; Hongwei Ouyang; Zhijian Xie; Ruikang Tang
Journal:  Nat Commun       Date:  2021-11-03       Impact factor: 14.919

10.  Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.

Authors:  Dongbo Li; Hongfei Ji; Xingjian Niu; Lei Yin; Yiran Wang; Yucui Gu; Jinlu Wang; Xiaoping Zhou; Han Zhang; Qingyuan Zhang
Journal:  Cancer Sci       Date:  2019-12-19       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.